PubMed ID: 31826238 Author(s): Georgiou M, Robson AG, Singh N, Pontikos N, Kane T, Hirji N, Ripamonti C, Rotsos T, Dubra A, Kalitzeos A, Webster AR, Carroll J, Michaelides M. Deep phenotyping of PDE6C-associated achromatopsia. …
eyes
RISK FACTORS FOR HEARING IMPAIRMENT IN TYPE 1 DIABETES.
PubMed ID: 31412233 Author(s): Braffett BH, Lorenzi GM, Cowie CC, Gao X, Bainbridge KE, Cruickshanks KJ, Kramer JR, Gubitosi-Klug RA, Larkin ME, Barnie A, Lachin JM, Schade DS; DCCT/EDIC Research Group. Risk factors for hearing …
Prevalence, Risk, and Genetic Association of Reticular Pseudodrusen in Age-related Macular Degeneration: Age-Related Eye Disease Study 2 Report 21.
PubMed ID: 31558345 Author(s): Domalpally A, Agrón E, Pak JW, Keenan TD, Ferris FL 3rd, Clemons TE, Chew EY. Prevalence, risk, and genetic association of reticular pseudodrusen in age-related macular degeneration: Age-Related Eye Disease Study …
Use of the Delphi process for defining successful outcomes for strabismus surgery.
PubMed ID: 31586584 Author(s): Serafino M, Granet DB, Kushner BJ, Dagi LR, Kekunnaya R, Nucci P. Use of the Delphi process for defining successful outcomes for strabismus surgery. J AAPOS. 2019 Dec;23(6):309-312. doi: 10.1016/j.jaapos.2019.07.006. Epub …
Synthesis, characterization, anti-proliferative properties and DNA binding of benzochromene derivatives: Increased Bax/Bcl-2 ratio and caspase-dependent apoptosis in colorectal cancer cell line.
PubMed ID: 31590040 Author(s): Ahagh MH, Dehghan G, Mehdipour M, Teimuri-Mofrad R, Payami E, Sheibani N, Ghaffari M, Asadi M. Synthesis, characterization, anti-proliferative properties and DNA binding of benzochromene derivatives: Increased Bax/Bcl-2 ratio and caspase-dependent …
Month 24 Outcomes After Treatment Initiation With Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal or Hemiretinal Vein Occlusion: SCORE2 Report 10: A Secondary Analysis of the SCORE2 Randomized Clinical Trial.
PubMed ID: 31600368 Author(s): Scott IU, Oden NL, VanVeldhuisen PC, Ip MS, Blodi BA, Chan CK; SCORE2 Investigator Group. Month 24 outcomes after treatment initiation with anti-vascular endothelial growth factor therapy for macular edema due …
Ocular Syphilis: Clinical Manifestations and Treatment Course.
PubMed ID: 31978289 Author(s): Etheridge T, Bowen RC, Raven M, Snow KB, Urban AW, Chang JS. Ocular syphilis: clinical manifestations and treatment course. WMJ. 2019 Dec;118(4):191-195. PMID 31978289 Journal: Wmj : Official Publication Of The …
Different Factors Associated with 2-Year Outcomes in Patients with Branch versus Central Retinal Vein Occlusion Treated with Ranibizumab.
PubMed ID: 31543350 Author(s): Sophie R, Wang PW, Channa R, Quezada-Ruiz C, Clark A, Campochiaro PA. Different factors associated with 2-year outcomes in patients with branch versus central retinal vein occlusion treated with Ranibizumab. Ophthalmology. …
Role of Fibronectin in Primary Open Angle Glaucoma.
PubMed ID: 31779192 Author(s): Faralli JA, Filla MS, Peters DM. Role of fibronectin in primary open angle glaucoma. Cells. 2019 Nov 26;8(12). pii: E1518. doi: 10.3390/cells8121518. Review. PMID 31779192 Journal: Cells, Volume 8, Issue 12, …